As with all plasma-derived therapeutics, the potential to transmit infectious agents cannot be totally eliminated.

That is why we introduced caprylate, a naturally occurring fatty acid that inactivates viruses almost instantly compared with other inactivation methods that can take hours.

We also have introduced a variety of independent pathogen safety steps in its manufacturing process that both inactivate and remove viruses and prions. Distinct mechanisms of pathogen reduction provide additional assurances that the novel manufacturing process for Gamunex^® may also offer protection against unknown/emerging pathogens.